- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03842293
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
The National Institutes of Health (NIH)-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) network has developed over 20 pediatric instruments, both child-report and parent-proxy editions. Cross-sectional evaluations of the validity of the instruments have established that they are ready for integration into clinical research and practice. The next step in their ongoing evaluation is to assess their prospective clinical validity in a variety of health conditions. This study addresses the clinical evaluation of the measures in children with chronic kidney disease (CKD).
Through baseline surveys and six follow-up surveys over a two-year period, Investigators are collecting self-report (child) and parent-proxy report of 11 pediatric PROMIS measures. Each of these PROMIS measures is described in the Main Outcome Measures section. Investigators are also collecting assessments of disease activity from clinical data. The selection of self-report and parent proxy patient-reported outcome (PRO) measures were determined through qualitative content validation. The analytic goal of this project is to evaluate baseline (cross-sectional) and longitudinal associations between PROMIS pediatric outcome measures and changes in the clinical status of patients with CKD. Our primary hypothesis is that as kidney function declines, self-reported health will worsen.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, MB R3E 3P4
- Children's Hospital Research Institute of Manitoba
-
-
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35205
- Children's Hospital of Alabama
-
-
California
-
Los Angeles, California, Verenigde Staten, 90095
- UCLA
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30322
- Children's Healthcare of Atlanta
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Riley Hospital for Children
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21287
- Johns Hopkins Children's Center
-
-
Michigan
-
Ann Arbor, Michigan, Verenigde Staten, 48109
- University of Michigan, Mott Hospital
-
-
Missouri
-
Kansas City, Missouri, Verenigde Staten, 64108
- Children's Mercy Hospital
-
Saint Louis, Missouri, Verenigde Staten, 63110
- St. Louis Children's Hospital
-
-
North Carolina
-
Charlotte, North Carolina, Verenigde Staten, 28203
- Levine Children's
-
-
Ohio
-
Cincinnati, Ohio, Verenigde Staten, 45229
- Cincinnati Children's Hospital and Medical Center
-
Cleveland, Ohio, Verenigde Staten, 44195
- Cleveland Clinic
-
Columbus, Ohio, Verenigde Staten, 43205
- Nationwide Children's Hopsital
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97201
- Oregon Health and Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Children's Hospital of Philadelphia
-
-
Washington
-
Seattle, Washington, Verenigde Staten, 98105
- Seattle Children's Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Child is 8-21 years old at time of enrollment
- Child is a Chronic Kidney Disease in Children (CKiD) patient OR a child who receives pediatric nephrology care at a CKiD site that participates in PEDSnet, a national pediatric learning health system
- Child seen by a pediatric nephrologist in the past 24 months
- Child has two eGFR readings (computed from serum creatinine) between 6-89 ml/min at least 3 months apart (eGFR of this level indicates CKD)
- Child speaks English
- Parent is the parent or legal guardian for the child
- Parent speaks English
Exclusion Criteria:
- Child is currently receiving dialysis
- Child received a kidney transplant
- Child has a parent-reported cognitive limitation that would preclude them from completing a questionnaire
- Child does not speak English
- Parent does not speak English
- Parent is not the parent of legal guardian for the child
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Cohort
- Tijdsperspectieven: Prospectief
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Longitudinal change in sleep disturbance
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 8 items from PROMIS sleep-related disturbance domain.
Participants rate their experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in sleep-related impairment
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 4 items from PROMIS sleep-related impairment domain.
Participants rate their experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in fatigue
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 8 items from PROMIS fatigue domain.
Participants rate their experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in life satisfaction
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 4 items from from PROMIS life satisfaction domain.
Participants rate their experience using a five point scale ranging from not at all to quite a bit.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in meaning and purpose
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 4 items from from PROMIS meaning and purpose domain.
Participants rate their experience using a five point scale ranging from not at all to quite a bit.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in psychological stress experiences
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Child self-report of 4 items from from PROMIS psychological stress experiences domain.
Participants rate their experience using a five point scale ranging from not at all to quite a bit.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in global health
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Parent proxy report of 7 items from from PROMIS global health domain.
Parents rate their child's experience using a five point scale ranging from poor to excellent.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in depressive symptoms
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Parent proxy report of 4 items from from PROMIS emotional distress - depressive symptoms domain.
Parents rate their child's experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in anxiety
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Parent proxy report of 4 items from from PROMIS emotional distress - anxiety domain.
Parents rate their child's experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in positive affect
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Parent proxy report of 4 items from from PROMIS positive affect domain.
Parents rate their child's experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
|
Longitudinal change in family relationships
Tijdsspanne: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Parent proxy report of 4 items from from PROMIS family relationships domain.
Parents rate their child's experience using a five point scale ranging from never to always.
Answers are converted to a t-score to compare to the general population.
|
Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Susan Furth, MD, Children's Hospital of Philadelphia
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 17-013723
- 1U19AR069525 (Subsidie/contract van de Amerikaanse NIH)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .